To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the future projected need for Advanced Therapy Medicinal Technologies; and what assessment he has made of the adequacy of the proposed NHS England/NICE Innovative Medicines Fund to meet that need.
Answered on
26 July 2022
No specific estimate has been made. The National Institute for Health and Care Excellence (NICE) has recommended several advanced therapeutic medicinal products (ATMPs) which are now routinely funded for National Health Service patients.
The Innovative Medicines Fund was recently launched to allow patients to benefit from early access to the most promising medicines where NICE is unable to recommend routine funding due to clinical uncertainty. This will support the rapid introduction of effective new medicines, including ATMPs.